Search

everythinglearnresearchcommunity

for

Search:↓

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Hair transplant worked for a patient with a specific scalp condition after breast cancer chemotherapy.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Women who had cancer treatment feel both positive and negative about their bodies.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.